// company-profile
Fulcrum Therapeutics, Inc. Insider Trading
FULCEvery SEC Form 4 insider trading filing for Fulcrum Therapeutics, Inc. (FULC) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
curl "https://api.form4api.com/v1/transactions?ticker=FULC" -H "X-Api-Key: YOUR_API_KEY"// activity-summary
Recent insider activity is bullish. Over the last 30 days, 6 insiders purchased shares (net $1.5M). Buying was led by TANG KEVIN.
// 90-day insight
Over the last 90 days, Fulcrum Therapeutics, Inc. insiders bought $1.5M across 14 transactions with no open-market sales.
- Most active insider: TANG KEVIN with 6 transactions totaling $1.5M.
- Largest single purchase: $415K by TANG KEVIN on Jul 16, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Fulcrum Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 17, 2026 | TANG KEVIN | FULC | Purchase | 50,945 | $3.52 | $179K |
| Jul 16, 2026 | TANG KEVIN | FULC | Purchase | 116,671 | $3.56 | $415K |
| Jul 15, 2026 | TANG KEVIN | FULC | Purchase | 107,377 | $3.56 | $382K |
| Jul 14, 2026 | TANG KEVIN | FULC | Purchase | 75,952 | $3.58 | $272K |
| Jul 14, 2026 | TANG KEVIN | FULC | Purchase | 53,651 | $3.56 | $191K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →